Functional Genomics of Brain Aging and Alzheimers Disease: Focus on Selective Neuronal Vulnerability
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Pivotal brain functions, such as neurotransmission, cognition, and memory, decline with advancing age and, especially, in neurodegenerative conditions associated with aging, such as Alzheimers disease (AD). Yet, deterioration in structure and function of the nervous system during aging or in AD is not uniform throughout the brain. Selective neuronal vulnerability (SNV) is a general but sometimes overlooked characteristic of brain aging and AD. There is little known at the molecular level to account for the phenomenon of SNV. Functional genomic analyses, through unbiased whole genome expression studies, could lead to new insights into a complex process such as SNV. Genomic data generated using both human brain tissue and brains from animal models of aging and AD were analyzed in this review. Convergent trends that have emerged from these data sets were considered in identifying possible molecular and cellular pathways involved in SNV. It appears that during normal brain aging and in AD, neurons vulnerable to injury or cell death are characterized by significant decreases in the expression of genes related to mitochondrial metabolism and energy production. In AD, vulnerable neurons also exhibit down-regulation of genes related to synaptic neurotransmission and vesicular transport, cytoskeletal structure and function, and neurotrophic factor activity. A prominent category of genes that are up-regulated in AD are those related to inflammatory response and some components of calcium signaling. These genomic differences between sensitive and resistant neurons can now be used to explore the molecular underpinnings of previously suggested mechanisms of cell injury in aging and AD. Keywords: Selective neuronal vulnerability, aging, Alzheimer's disease, functional genomics, neuroinflammation, energy metabolism, synaptic neurotransmission, amyotrophic lateral sclerosis, laser capture microdissection, (LCM), protein phosphatase 2, catalytic subunit, isoform, Calm2, calmodulin 2, amyloid peptides, senile plaques (SPs), neurofibrillary tangles (NFTs), electron transport chain (ETC), presenilin 1, Cytochrome c oxidase, Cytochrome bc-1 complex core protein, neuritin, synapsin I, synapsin II, synaptobrevin, synaptojanin, synaptophysin, synaptopodin, synaptotagmin, syntaxin, synuclein, inositol trisphosphate, Ca2+-regulated phosphatase calcineurin, -tubulin
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744 · cited 1×
“Region-specific dysfunction in synaptic transmission may result not only from the down-regulation of the genes described above, but also from direct effects of A on synaptic macromolecules [120, 121], or from the effects of products of chronic inflammatory response, such as tumor necrosis factor [122], or from other f…”
BackgroundAlzheimer's disease: cell-specific pathology isolates the hippocampal formation.
Hyman, B. T., Van Hoesen, G. W., Damasio, A. R., & Barnes, C. L. (1984) · Science · doi:10.1126/science.6474172 · Cited by 2,268
Gene regulation and DNA damage in the ageing human brain
Lu, T., Pan, Y., Kao, S.-Y., Li, C., Kohane, I., Chan, J., & Yankner, B. A. (2004) · Nature · doi:10.1038/nature02661 · Cited by 1,874
Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease
Gómez-Isla, T., Price, J. L., McKeel Jr., D. W., Morris, J. C., Growdon, J. H., & Hyman, B. T. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-14-04491.1996 · Cited by 1,796 · cited 1×
“The cerebral cortex, especially the association areas, and the hippocampus, are the predominant regions of AD pathology [4, 50, 51].”
BackgroundNeuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease
Gómez‐Isla, T., Hollister, R., West, H., Mui, S., Growdon, J. H., Petersen, R. C., Parisi, J. E., & Hyman, B. T. (1997) · Annals of Neurology · doi:10.1002/ana.410410106 · Cited by 1,489 · cited 1×
“The cerebral cortex, especially the association areas, and the hippocampus, are the predominant regions of AD pathology [4, 50, 51].”
BackgroundArnold, S. E., Hyman, B. T., Flory, J., Damasio, A. R., & Van Hoesen, G. W. (1991) · Cerebral Cortex · doi:10.1093/cercor/1.1.103 · Cited by 1,380
Life and Death of Neurons in the Aging Brain
Morrison, J. H., & Hof, P. R. (1997) · Science · doi:10.1126/science.278.5337.412 · Cited by 1,344
Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease
Hirsch, E., Graybiel, A. M., & Agid, Y. A. (1988) · Nature · doi:10.1038/334345a0 · Cited by 1,301 · cited 1×
“Besides aging and AD, this phenomenon, of selective neuronal vulnerability (SNV), is also a characteristic of many other neural insults, such as Parkinson’s disease [11], amyotrophic lateral sclerosis (ALS) [12], ischemia [13], epileptic seizures [14], and oxidative stress (OS) [15, 16].”
BackgroundDifferences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease
West, M. J., Coleman, P. D., Flood, D. G., & Troncoso, J. C. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92338-8 · Cited by 1,267 · cited 1×
“These observations have led to the assertion that most of the functional decline associated with normal aging is caused by relatively subtle changes, such as loss of dendrites, reductions in spine densities, altered spine morphologies, or changes in the molecular profile of synapses [21, 28-31].”
BackgroundSoluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior
Selkoe, D. J. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.02.016 · Cited by 1,038
Blalock, E. M., Geddes, J. W., Chen, K. C., Porter, N. M., Markesbery, W. R., & Landfield, P. W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308512100 · Cited by 1,025
Pearson, R. C., Esiri, M. M., Hiorns, R. W., Wilcock, G. K., & Powell, T. P. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.13.4531 · Cited by 987
Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age
Corral-Debrinski, M., Horton, T., Lott, M. T., Shoffner, J. M., Flint Beal, M., & Wallace, D. C. (1992) · Nature Genetics · doi:10.1038/ng1292-324 · Cited by 890 · cited 1×
“An associated effect derived from the low levels of mitochondrial metabolic activity in aging cerebellum would be a lowering of the levels of reactive oxygen species (ROS) and OS, as well as of DNA oxidative damage that results from elevations in ROS levels in neurons [47, 48].”
BackgroundCerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer’s disease
Small, G. W., Ercoli, L. M., Silverman, D. H. S., Huang, S.-C., Komo, S., Bookheimer, S. Y., Lavretsky, H., Miller, K., Siddarth, P., Rasgon, N. L., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090106797 · Cited by 790 · cited 1×
“Since the metabolic activity of the brain is very high, accounting for an estimated 20-25% of glucose and oxygen utilization in the body, it is not surprising that reduced metabolism and energy production might be significantly correlated with cognitive decline in AD [75, 76].”
BackgroundOxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain
Mecocci, P., MacGarvey, U., Kaufman, A. E., Koontz, D., Shoffner, J. M., Wallace, D. C., & Beal, M. F. (1993) · Annals of Neurology · doi:10.1002/ana.410340416 · Cited by 757 · cited 1×
“An associated effect derived from the low levels of mitochondrial metabolic activity in aging cerebellum would be a lowering of the levels of reactive oxygen species (ROS) and OS, as well as of DNA oxidative damage that results from elevations in ROS levels in neurons [47, 48].”
BackgroundRegional aerobic glycolysis in the human brain
Vaishnavi, S. N., Vlassenko, A. G., Rundle, M. M., Snyder, A. Z., Mintun, M. A., & Raichle, M. E. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010459107 · Cited by 738
de Leon, M. J., Convit, A., Wolf, O. T., Tarshish, C. Y., DeSanti, S., Rusinek, H., Tsui, W., Kandil, E., Scherer, A. J., Roche, A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191044198 · Cited by 629
Davies, C. A., Mann, D. M. A., Sumpter, P. Q., & Yates, P. O. (1987) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(87)90057-8 · Cited by 628 · cited 1×
“This observation suggests a selective weakening or loss of neuronal connections in ADaffected brain regions, and may help explain the decreases in synaptic density observed by quantitative morphometric analyses performed on brain regions vulnerable to ADinduced damage [114-116].”
BackgroundGene expression changes in the course of normal brain aging are sexually dimorphic
Berchtold, N. C., Cribbs, D. H., Coleman, P. D., Rogers, J., Head, E., Kim, R., Beach, T., Miller, C., Troncoso, J., Trojanowski, J. Q., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806883105 · Cited by 626
Neuron Number in the Entorhinal Cortex and CA1 in Preclinical Alzheimer Disease
Price, J. L., Ko, A. I., Wade, M. J., Tsou, S. K., McKeel, D. W., & Morris, J. C. (2001) · Archives of Neurology · doi:10.1001/archneur.58.9.1395 · Cited by 596
Liang, W. S., Reiman, E. M., Valla, J., Dunckley, T., Beach, T. G., Grover, A., Niedzielko, T. L., Schneider, L. E., Mastroeni, D., Caselli, R., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709259105 · Cited by 585 · cited 1×
“It is important to point out that in addition to the lower expression levels of genes related to ETC enzymes in vulnerable neurons in the AD brain, those for subunits of the translocases of the outer and inner mitochondrial membranes (Tomm and Timm) are also down-regulated in these regions [91].”
BackgroundLewis, D., Campbell, M., Terry, R., & Morrison, J. (1987) · The Journal of Neuroscience · doi:10.1523/jneurosci.07-06-01799.1987 · Cited by 578 · cited 1×
“In contrast to neurons in these regions that contain high levels of NFT’s, primary sensory and motor neurons are largely spared in the disease [59, 60].”
BackgroundThe Alzheimer’s Disease Mitochondrial Cascade Hypothesis
Swerdlow, R. H., Burns, J. M., & Khan, S. M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100339 · Cited by 562 · cited 1×
“, the mitochondrial cascade hypothesis [125], the Ca 2+ hypothesis of aging and AD [126, 127], the synaptic disruption hypothesis of AD and aging [128, 129], and the neuroinflammation hypothesis of aging and AD [130].”
BackgroundHippocampal formation glucose metabolism and volume losses in MCI and AD
De Santi, S., de Leon, M. J., Rusinek, H., Convit, A., Tarshish, C. Y., Roche, A., Tsui, W. H., Kandil, E., Boppana, M., Daisley, K., et al. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00230-5 · Cited by 548 · cited 1×
“Decreases in CMRGl in AD have been reported for regions that are most vulnerable as defined by neuropathological changes, including those of the frontal, parietal, temporal, and posterior cingulate cortex, as well as the hippocampus and entorhinal cortex [80-82].”
BackgroundAlexander, G. E., Chen, K., Pietrini, P., Rapoport, S. I., & Reiman, E. M. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.5.738 · Cited by 532
Colangelo, V., Schurr, J., Ball, M. J., Pelaez, R. P., Bazan, N. G., & Lukiw, W. J. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10351 · Cited by 517
Model‐guided microarray implicates the retromer complex in Alzheimer's disease
Small, S. A., Kent, K., Pierce, A., Leung, C., Kang, M. S., Okada, H., Honig, L., Vonsattel, J., & Kim, T. (2005) · Annals of Neurology · doi:10.1002/ana.20667 · Cited by 440 · cited 1×
“Genome HG-U133A VPS35 and retromer complex [132]”
Spatial correlation between brain aerobic glycolysis and amyloid-β (Aβ) deposition
Vlassenko, A. G., Vaishnavi, S. N., Couture, L., Sacco, D., Shannon, B. J., Mach, R. H., Morris, J. C., Raichle, M. E., & Mintun, M. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010461107 · Cited by 404 · cited 1×
“It is also highly significant that the regions that tend to accumulate the highest amounts of A in AD, or in cognitively normal individuals with amyloid plaques in their brain, differ from other brain regions in terms of the overall levels of glycolytic activity [83, 84].”
BackgroundHof, P. R., Morrison, J. H., & Cox, K. (1990) · Journal of Comparative Neurology · doi:10.1002/cne.903010105 · Cited by 365 · cited 1×
“pyramidal neurons in the areas mentioned above, particularly association neurons with long projections [61, 62].”
BackgroundAlzheimer's disease affects limbic nuclei of the thalamus
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00305867 · Cited by 328 · cited 1×
“Besides the neurons in the cerebral cortex and the hippocampus, many subcortical structures that have connections to the cerebral cortex also contain neurons with large amounts of NFTs, including the amygdala, nucleus basalis of Meynert, ventral tegmental area, dorsal raphe, locus coeruleus, olfactory bulb, and some m…”
BackgroundLiang, W. S., Dunckley, T., Beach, T. G., Grover, A., Mastroeni, D., Ramsey, K., Caselli, R. J., Kukull, W. A., McKeel, D., Morris, J. C., et al. (2008) · Physiological Genomics · doi:10.1152/physiolgenomics.00242.2007 · Cited by 309 · cited 2×
“As shown in Tables 1 and 2, the down-regulation of genes related to metabolic homeostasis and energy production is a recurring theme in AD brains [71, 72, 85-90].”
BackgroundResultBentourkia, M., Bol, A., Ivanoiu, A., Labar, D., Sibomana, M., Coppens, A., Michel, C., Cosnard, G., & De Volder, A. G. (2000) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00396-8 · Cited by 189 · cited 1×
“The differential response of cerebellar neurons at middle age and old age might be due to the lower metabolic rate of cerebellar neurons as has been observed for both human and primate brains [44-46].”
BackgroundRegional synaptic pathology in Alzheimer's disease
Honer, W. G., Dickson, D. W., Gleeson, J., & Davies, P. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90111-a · Cited by 179
Aging and Gene Expression in the Primate Brain
Fraser, H. B., Khaitovich, P., Plotkin, J. B., Pääbo, S., & Eisen, M. B. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030274 · Cited by 172
Overmyer, M., Helisalmi, S., Soininen, H., Laakso, M., Riekkinen Sr., P., & Alafuzoff, I. (1999) · Acta Neuropathologica · doi:10.1007/s004010051002 · Cited by 91 · cited 1×
“Overall, these findings are consistent with other experimental evidence showing that in AD brains, inflammation is particularly localized in regions most affected by the disease [102-109].”
ResultRegional neuronal loss in aging and Alzheimer's disease: a brief review
O'Banion, M. K., Coleman, P. D., & Callahan, L. M. (1994) · Seminars in Neuroscience · doi:10.1006/smns.1994.1039 · Cited by 23 · cited 1×
“For example, in the hippocampus, neurons in the CA1 region are vulnerable to brain aging and AD, but those in the nearby CA3 region are not nearly as heavily damaged as the CA1 neurons [1-3].”
BackgroundMolecular signatures of neurodegeneration in the cortex of PS1/PS2 double knockout mice
Mirnics, K., Norstrom, E. M., Garbett, K., Choi, S., Zhang, X., Ebert, P., & Sisodia, S. S. (2008) · Molecular Neurodegeneration · doi:10.1186/1750-1326-3-14 · Cited by 23 · cited 2×
“These include: 1) Up-regulation in AD-vulnerable regions of genes related to calcium (Ca 2+ ) homeostasis and signaling pathways, such as the inositol trisphosphate (IP3)-receptor kinase and the Ca 2+ -regulated phosphatase calcineurin (Ppp3c), as well as the downregulation of genes encoding calcium binding proteins […”
Background
Cited by
Wang, M., Roussos, P., McKenzie, A., Zhou, X., Kajiwara, Y., Brennand, K. J., De Luca, G. C., Crary, J. F., Casaccia, P., Buxbaum, J. D., et al. (2016) · Genome Medicine · doi:10.1186/s13073-016-0355-3 · Cited by 314
Alzheimer's Association Calcium Hypothesis Workgroup, & Khachaturian, Z. S. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.12.006 · Cited by 311
Blalock, E. M., Buechel, H. M., Popovic, J., Geddes, J. W., & Landfield, P. W. (2011) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2011.06.007 · Cited by 211
Metabolomics of Human Brain Aging and Age-Related Neurodegenerative Diseases
Jové, M., Portero-Otín, M., Naudí, A., Ferrer, I., & Pamplona, R. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000091 · Cited by 195
Nuriel, T., Angulo, S. L., Khan, U., Ashok, A., Chen, Q., Figueroa, H. Y., Emrani, S., Liu, L., Herman, M., Barrett, G., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01444-0 · Cited by 181
Metadata
- Authors
- Wang, X., L. Michaelis, M., & K. Michaelis, E.
- Venue
- Current Genomics
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2010-12-01
- Volume
- 11
- Issue
- 8
- Pages
- 618-633
- ISSN
- 1389-2029 (ISSN-L)
- OpenAlex
- W2157921593
- Cited by
- 93
- References
- 38
- FWCI
- 2.28
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.